Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology
申请人:Aventis Pharma S.A.
公开号:US20040162276A1
公开(公告)日:2004-08-19
The present invention relates to novel compounds derived from indazoles or indoles of formula (1) or formula (2), to methods for treating tumors or cancerous cells with compounds of formula (1) or formula (2) and to pharmacaetutical compositions comprising a pharmaceutically acceptable carrier and a compound of formula (1) or formula (2).
1
本发明涉及从式(1)或式(2)的吲唑或吲哚衍生的新化合物,以及使用式(1)或式(2)的化合物治疗肿瘤或癌细胞的方法,还涉及包含药学上可接受的载体和式(1)或式(2)化合物的药物组合物。